Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study

Jonas Schiffmann, Maxine Sun, Giorgio Gandaglia, Zhe Tian, Ioana Popa, Alessandro Larcher, Malek Meskawi, Alberto Briganti, Michael McCormack, Shahrokh F. Shariat, Francesco Montorsi, Markus Graefen, Fred Saad, Pierre I. Karakiewicz

Research output: Contribution to journalArticle

Abstract

Introduction: We aimed to assess contemporary rates of neoadjuvant chemotherapy (NC) use. Methods: We relied on the Surveillance, Epidemiology and End Results (SEER)-Medicare database for non-metastatic, muscle-invasive (T2-T4a) urothelial carcinoma of the urinary bladder (UCUB) patients who underwent radical cystectomy (RC) between 1991 and 2009. Multivariable logistic regression analyses tested predictors of NC use, such as: T-stage, N-stage, year of diagnosis, age at diagnosis, gender, race, use of radiotherapy (RT), marital status, urban status, socioeconomic status, tumour grade, and Charlson comorbidity index (CCI). Results: Overall, 5207 patients treated with RC were identified. Of those, 332 (6.4%) received NC. The rate of NC increased over time from 6.1% (1991) to 15.0% (2009) (p

Original languageEnglish
Pages (from-to)E82-E86
JournalCanadian Urological Association Journal
Volume10
Issue number3-4
DOIs
Publication statusPublished - Mar 1 2016

Fingerprint

Cystectomy
Drug Therapy
Population
Marital Status
Medicare
Social Class
Comorbidity
Epidemiology
Urinary Bladder
Radiotherapy
Logistic Models
Regression Analysis
Databases
Carcinoma
Muscles
Neoplasms

ASJC Scopus subject areas

  • Urology
  • Oncology

Cite this

Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients : A population-based study. / Schiffmann, Jonas; Sun, Maxine; Gandaglia, Giorgio; Tian, Zhe; Popa, Ioana; Larcher, Alessandro; Meskawi, Malek; Briganti, Alberto; McCormack, Michael; Shariat, Shahrokh F.; Montorsi, Francesco; Graefen, Markus; Saad, Fred; Karakiewicz, Pierre I.

In: Canadian Urological Association Journal, Vol. 10, No. 3-4, 01.03.2016, p. E82-E86.

Research output: Contribution to journalArticle

Schiffmann, J, Sun, M, Gandaglia, G, Tian, Z, Popa, I, Larcher, A, Meskawi, M, Briganti, A, McCormack, M, Shariat, SF, Montorsi, F, Graefen, M, Saad, F & Karakiewicz, PI 2016, 'Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study', Canadian Urological Association Journal, vol. 10, no. 3-4, pp. E82-E86. https://doi.org/10.5489/cuaj.3292
Schiffmann, Jonas ; Sun, Maxine ; Gandaglia, Giorgio ; Tian, Zhe ; Popa, Ioana ; Larcher, Alessandro ; Meskawi, Malek ; Briganti, Alberto ; McCormack, Michael ; Shariat, Shahrokh F. ; Montorsi, Francesco ; Graefen, Markus ; Saad, Fred ; Karakiewicz, Pierre I. / Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients : A population-based study. In: Canadian Urological Association Journal. 2016 ; Vol. 10, No. 3-4. pp. E82-E86.
@article{850a99c38ec84a75be41c18622a891a7,
title = "Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients: A population-based study",
abstract = "Introduction: We aimed to assess contemporary rates of neoadjuvant chemotherapy (NC) use. Methods: We relied on the Surveillance, Epidemiology and End Results (SEER)-Medicare database for non-metastatic, muscle-invasive (T2-T4a) urothelial carcinoma of the urinary bladder (UCUB) patients who underwent radical cystectomy (RC) between 1991 and 2009. Multivariable logistic regression analyses tested predictors of NC use, such as: T-stage, N-stage, year of diagnosis, age at diagnosis, gender, race, use of radiotherapy (RT), marital status, urban status, socioeconomic status, tumour grade, and Charlson comorbidity index (CCI). Results: Overall, 5207 patients treated with RC were identified. Of those, 332 (6.4{\%}) received NC. The rate of NC increased over time from 6.1{\%} (1991) to 15.0{\%} (2009) (p",
author = "Jonas Schiffmann and Maxine Sun and Giorgio Gandaglia and Zhe Tian and Ioana Popa and Alessandro Larcher and Malek Meskawi and Alberto Briganti and Michael McCormack and Shariat, {Shahrokh F.} and Francesco Montorsi and Markus Graefen and Fred Saad and Karakiewicz, {Pierre I.}",
year = "2016",
month = "3",
day = "1",
doi = "10.5489/cuaj.3292",
language = "English",
volume = "10",
pages = "E82--E86",
journal = "Canadian Urological Association Journal",
issn = "1920-1214",
publisher = "Canadian Urological Association",
number = "3-4",

}

TY - JOUR

T1 - Suboptimal use of neoadjuvant chemotherapy in radical cystectomy patients

T2 - A population-based study

AU - Schiffmann, Jonas

AU - Sun, Maxine

AU - Gandaglia, Giorgio

AU - Tian, Zhe

AU - Popa, Ioana

AU - Larcher, Alessandro

AU - Meskawi, Malek

AU - Briganti, Alberto

AU - McCormack, Michael

AU - Shariat, Shahrokh F.

AU - Montorsi, Francesco

AU - Graefen, Markus

AU - Saad, Fred

AU - Karakiewicz, Pierre I.

PY - 2016/3/1

Y1 - 2016/3/1

N2 - Introduction: We aimed to assess contemporary rates of neoadjuvant chemotherapy (NC) use. Methods: We relied on the Surveillance, Epidemiology and End Results (SEER)-Medicare database for non-metastatic, muscle-invasive (T2-T4a) urothelial carcinoma of the urinary bladder (UCUB) patients who underwent radical cystectomy (RC) between 1991 and 2009. Multivariable logistic regression analyses tested predictors of NC use, such as: T-stage, N-stage, year of diagnosis, age at diagnosis, gender, race, use of radiotherapy (RT), marital status, urban status, socioeconomic status, tumour grade, and Charlson comorbidity index (CCI). Results: Overall, 5207 patients treated with RC were identified. Of those, 332 (6.4%) received NC. The rate of NC increased over time from 6.1% (1991) to 15.0% (2009) (p

AB - Introduction: We aimed to assess contemporary rates of neoadjuvant chemotherapy (NC) use. Methods: We relied on the Surveillance, Epidemiology and End Results (SEER)-Medicare database for non-metastatic, muscle-invasive (T2-T4a) urothelial carcinoma of the urinary bladder (UCUB) patients who underwent radical cystectomy (RC) between 1991 and 2009. Multivariable logistic regression analyses tested predictors of NC use, such as: T-stage, N-stage, year of diagnosis, age at diagnosis, gender, race, use of radiotherapy (RT), marital status, urban status, socioeconomic status, tumour grade, and Charlson comorbidity index (CCI). Results: Overall, 5207 patients treated with RC were identified. Of those, 332 (6.4%) received NC. The rate of NC increased over time from 6.1% (1991) to 15.0% (2009) (p

UR - http://www.scopus.com/inward/record.url?scp=84960807777&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84960807777&partnerID=8YFLogxK

U2 - 10.5489/cuaj.3292

DO - 10.5489/cuaj.3292

M3 - Article

AN - SCOPUS:84960807777

VL - 10

SP - E82-E86

JO - Canadian Urological Association Journal

JF - Canadian Urological Association Journal

SN - 1920-1214

IS - 3-4

ER -